In re: Lamictal Direct Purchas, et al, et al
| GLAXOSMITHKLINE LLC, DBA SmithKline Beecham Corp, TEVA PHARMACEUTICAL INDUSTRIES LTD and TEVA PHARMACEUTICALS USA INC |
| ROCHESTER DRUG COOPERATIVE INC, KING DRUG CO OF FLORENCE INC, on behalf of itself and all others similarly situated and LOUISIANA WHOLESALE DRUG CO INC, on behalf of itself and all others similarly situated |
| 19-1655 |
| March 27, 2019 |
| U.S. Court of Appeals, Third Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
 In re: Lamictal Direct Purchaser Antitrust Litigation
|
Docket Report
RSS Track this Docket
This docket was last retrieved on May 22, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| HARD COPY RECEIVED from Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc - Brief with Volume I of Appendix attached. Copies: 1. (SJB) [Entered: 05/22/2019 10:58 AM] |
| HARD COPY RECEIVED from Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc - Brief with Volume I of Appendix attached. Copies: 7 (FILED UNDER SEAL) (SJB) [Entered: 05/22/2019 11:00 AM] |
| HARD COPY RECEIVED from Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc - Appendix. Copies: 4. Volumes: 5 (Volume I attached to Brief). Volume 3 - 5 filed under SEAL. (MS) [Entered: 05/23/2019 01:56 PM] |
| HARD COPY RECEIVED from Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc - Redacted Appendix Vol. III. Copies: 4. (MS) [Entered: 05/23/2019 01:58 PM] |
| ECF FILER: ELECTRONIC BRIEF with Volume I of Appendix attached on behalf of Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. Certificate of Service dated 05/21/2019 by ECF. [19-1655] (DWA) [Entered: 05/21/2019 05:00 PM] |
| ECF FILER: SEALED ELECTRONIC BRIEF with Volume I of Appendix attached on behalf of Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. Certificate of Service dated 05/21/2019 by 3rd party, ECF. [19-1655] (DWA) [Entered: 05/21/2019 05:03 PM] |
| ECF FILER: JOINT SEALED Motion filed by Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc to seal portions of joint appendix and brief. Certificate of Service dated 05/21/2019. [19-1655] (DWA) [Entered: 05/21/2019 04:52 PM] |
| ECF FILER: SEALED ELECTRONIC JOINT APPENDIX on behalf of Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. Certificate of Service dated 05/21/2019 by 3rd party, ECF. [19-1655] (DWA) [Entered: 05/21/2019 05:19 PM] |
| ECF FILER: ELECTRONIC JOINT APPENDIX on behalf of Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. Certificate of service dated 05/21/2019 by ECF. [19-1655] (DWA) [Entered: 05/21/2019 05:13 PM] |
| ECF FILER: AMENDED DISCLOSURE STATEMENT on behalf of Appellant GlaxoSmithKline LLC, filed. [19-1655] (DJB) [Entered: 04/15/2019 10:39 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Joseph A. Fischetti on behalf of Appellant(s) GlaxoSmithKline, LLC f/k/a SmithKline Beecham Corporation. [19-1655] (JAF) [Entered: 04/12/2019 08:16 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Gavin J. Rooney on behalf of Appellant(s) GlaxoSmithKline, LLC f/k/a SmithKline Beecham Corporation. [19-1655] (GJR) [Entered: 04/12/2019 08:14 AM] |
| BRIEFING NOTICE ISSUED. Brief on behalf of Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc due on or before 05/21/2019. Appendix due on or before 05/21/2019. (PDB) [Entered: 04/11/2019 02:18 PM] |
| ECF FILER: Concise Summary of the Case filed by Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, received. [19-1655] (LMW) [Entered: 04/10/2019 10:51 AM] |
| ECF FILER: DISCLOSURE STATEMENT on behalf of Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. [19-1655] (LMW) [Entered: 04/10/2019 10:35 AM] |
| ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc, filed. [19-1655] (LMW) [Entered: 04/10/2019 10:53 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Devora W. Allon on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.. [19-1655] (DWA) [Entered: 04/10/2019 01:26 PM] |
| ECF FILER: ENTRY OF APPEARANCE from Thomas S. Burnett on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.. [19-1655] (TSB) [Entered: 04/10/2019 01:30 PM] |
| ECF FILER: ENTRY OF APPEARANCE from Dmitriy Tishyevich on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.. [19-1655] (DT) [Entered: 04/10/2019 01:29 PM] |
| ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc advising this court that transcripts are not needed. [19-1655] (LMW) [Entered: 04/10/2019 10:34 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Katherine M. Romano on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.. [19-1655] (KMR) [Entered: 04/10/2019 10:17 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Liza M. Walsh on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd.. [19-1655] (LMW) [Entered: 04/10/2019 10:14 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Ms. Robin P. Sumner on behalf of Appellant(s) GlaxoSmithKline, LLC f/k/a SmithKline Beecham Corporation. [19-1655] (RPS) [Entered: 04/09/2019 09:53 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Ms. Lindsay D. Breedlove on behalf of Appellant(s) GlaxoSmithKline, LLC f/k/a SmithKline Beecham Corporation. [19-1655] (LDB) [Entered: 04/09/2019 09:55 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Mr. Daniel J. Boland on behalf of Appellant(s) GlaxoSmithKline, LLC f/k/a SmithKline Beecham Corporation. [19-1655] (DJB) [Entered: 04/09/2019 09:57 AM] |
| ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant GlaxoSmithKline LLC, filed. [19-1655] (DJB) [Entered: 04/09/2019 09:59 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Matthew F. Gately on behalf of Respondent(s) Rochester Drug Co-Operative, Inc., King Drug Company of Florence, Inc., Louisiana Wholesale Drug Co., Inc., and the Direct Purchaser Class. [19-1655] (MFG) [Entered: 04/05/2019 12:18 PM] |
| ECF FILER: LETTER from Attorney Daniel J. Boland, Esq. for Appellant GlaxoSmithKline LLC Letter from Dan Boland re: proper party name for GSK. Certificate of Service dated 04/02/2019. Service made by ECF. [19-1655] (DJB) [Entered: 04/02/2019 11:50 AM] |
| ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Louisiana Wholesale Drug Co Inc, filed. [19-1655] (EKC) [Entered: 04/02/2019 03:00 PM] |
| ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee Rochester Drug Cooperative Inc, filed. [19-1655] (PK) [Entered: 04/02/2019 02:08 PM] |
| ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee King Drug Co of Florence Inc, filed. [19-1655] (EKC) [Entered: 04/02/2019 03:01 PM] |
| ECF FILER: Letter from Liza M. Walsh re: proper party names for the Teva Appellants filed by Appellants Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA Inc. Certificate of Service dated 04/01/2019. Service made by ECF. [19-1655] (LMW) [Entered: 04/01/2019 02:27 PM] |
| ECF FILER: ENTRY OF APPEARANCE from Caitlin G Coslett on behalf of Respondent(s) Rochester Drug Co-Operative, Inc.. [19-1655] (CGC) [Entered: 03/29/2019 03:19 PM] |
| ECF FILER: ENTRY OF APPEARANCE from David F. Sorensen on behalf of Respondent(s) Rochester Drug Co-Operative, Inc.. [19-1655] (DFS) [Entered: 03/28/2019 11:43 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Elena K. Chan on behalf of Respondent(s) King Drug Co. of Florence Inc.; Louisiana Wholesale Drug Co. Inc.. [19-1655] (EKC) [Entered: 03/28/2019 11:58 AM] |
| ECF FILER: ENTRY OF APPEARANCE from Bruce E. Gerstein on behalf of Respondent(s) King Drug Co. of Florence Inc.; Louisiana Wholesale Drug Co. Inc.. [19-1655] (BEG) [Entered: 03/28/2019 12:01 PM] |
| ECF FILER: ENTRY OF APPEARANCE from Joseph Opper on behalf of Respondent(s) King Drug Co. of Florence Inc.; Louisiana Wholesale Drug Co. Inc.. [19-1655] (JO) [Entered: 03/28/2019 12:03 PM] |
| RECORD available on District Court CM/ECF. (PDB) [Entered: 03/27/2019 11:28 AM] |
ORDER (Clerk) The Court granted Petitioners' Petition for Leave to Appeal pursuant to Fed. R. Civ. P. 23(f) on March 18, 2019. The appeal will be docketed at No. 19-1655. It is noted Petitioners were inconsistent designating parties as Petitioners in No. 18-8061. If the Clerk has designated the incorrect corporate parties as Appellants, counsel for Appellants must file a letter motion setting forth the proper Appellants within seven (7) days of the date of this order, filed. (PDB) [Entered: 03/27/2019 11:36 AM]
|
| ECF FILER: ENTRY OF APPEARANCE from Peter R. Kohn on behalf of Respondent(s) Rochester Drug Co-Operative, Inc., King Drug Company of Florence, Inc., Louisiana Wholesale Drug Co., Inc., and the Direct Purchaser Class. [19-1655] (PK) [Entered: 03/27/2019 04:32 PM] |
| CIVIL CASE DOCKETED. Notice filed by Appellants GlaxoSmithKline LLC, Teva Pharmaceutical Industries Ltd and Teva Pharmaceuticals USA, Inc in District Court No. 2-12-cv-00995. (Case transferred from Misc. Dokcet No. 18-8061) (PDB) [Entered: 03/27/2019 11:22 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
